GIM
NKTR icon

Granahan Investment Management’s Nektar Therapeutics NKTR Stock Holding History

Granahan Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,434
Closed -$9.35M – 216
2017
Q4 		$9.35M Sell
10,434
-21,819
-68% -$12.9M 0.74% 43
2017
Q3 		$11.6M Buy
32,253
+1,640
+5% +$513K 0.97% 28
2017
Q2 		$8.98M Sell
30,613
-6,885
-18% -$1.99M 0.83% 35
2017
Q1 		$13.2M Sell
37,498
-83,589
-69% -$18.8M 1.32% 17
2016
Q4 		$22.3M Sell
121,087
-11,788
-9% -$2.4M 0.77% 41
2016
Q3 		$34.2M Buy
132,875
+853
+0.6% +$220K 1.12% 17
2016
Q2 		$28.2M Sell
132,022
-4,767
-3% -$1.07M 1.03% 23
2016
Q1 		$28.2M Sell
136,789
-2,021
-1% -$388K 1.03% 26
2015
Q4 		$35.1M Sell
138,810
-15,835
-10% -$3.26M 1.21% 12
2015
Q3 		$25.4M Buy
154,645
+7,127
+5% +$1.26M 0.79% 38
2015
Q2 		$27.7M Sell
147,518
-278
-0.2% -$47.8K 0.78% 41
2015
Q1 		$24.4M Sell
147,796
-86,203
-37% -$17.7M 0.7% 51
2014
Q4 		$54.4M Buy
233,999
+4,467
+2% +$955K 1.59% 4
2014
Q3 		$41.6M Sell
229,532
-15,423
-6% -$2.95M 1.28% 12
2014
Q2 		$47.1M Sell
244,955
-1,309
-0.5% -$232K 1.37% 10
2014
Q1 		$44.8M Buy
246,264
+31,070
+14% +$6.15M 1.21% 11
2013
Q4 		$36.6M Buy
215,194
+34,205
+19% +$5.52M 0.94% 27
2013
Q3 		$28.4M Sell
180,989
-11,424
-6% -$2.11M 0.75% 46
2013
Q2 		$33.3M Buy
+192,413
New +$29.5M 0.96% 25

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Granahan Investment Management's NKTR Position: Q1 2018 in Review

Granahan Investment Management sold out of Nektar Therapeutics (NKTR) in Q1 2018, closing a stake of 10,434 shares — an estimated $9.35M sold.

Granahan Investment Management first reported a position in NKTR in Q2 2013 and held it in 19 quarters. The position peaked at $54.4M in Q4 2014. 359 funds tracked by Wall St. Rank hold NKTR as of Q1 2018.

  • Granahan Investment Management reported no remaining Nektar Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Granahan Investment Management sold 10,434 Nektar Therapeutics shares in Q1 2018, an estimated $9.35M.
  • Granahan Investment Management first reported a position in Nektar Therapeutics in Q2 2013 and held it in 19 quarters.
  • Granahan Investment Management's Nektar Therapeutics position peaked at $54.4M in Q4 2014.
  • 359 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2018.

Based on Granahan Investment Management's 13F filing for Q1 2018, filed 14 May 2018.